IanJonathanDavisMDPhD
Pediatric Hematology & Oncology • Chapel Hill, NCDivision Chief and Start H. Gold Distinguished Professor, Pediatrics and Genetics, University of North Carolina at Chapel Hill School of Medicine
Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-966-5360Fax+1 919-966-8212
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1995 - 1999
Northwestern University The Feinberg School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2006 - 2025
MA State Medical License 1998 - 2007- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 2 citationsType II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation.Sonia J Laurie, Joseph P Foster 2nd, Danny W Bruce, Hemamalini Bommiasamy, Oleg V Kolupaev
Nature Communications. 2024-07-17 - Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma.Le Yu, Yu Deng, Xiaodong Wang, Charlene Santos, Ian J Davis
Nature Communications. 2024-06-21 - 3 citationsCHD4 and SMYD1 repress common transcriptional programs in the developing heart.Wei Shi, Lauren K Wasson, Kerry M Dorr, Zachary L Robbe, Caralynn M Wilczewski
Development. 2024-04-15
Press Mentions
Immune Cell Transformation Can Influence Stem Cell Transplant Success in Cancer PatientsJuly 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
